German Inclisiran Network: Retrospective Registry of Patients Being Treated With the siRNA Inclisiran in Germany (GIN)

J

Jena University Hospital

Status

Enrolling

Conditions

Hypercholesterolemia

Study type

Observational

Funder types

Other

Identifiers

NCT05438069
2021-2429

Details and patient eligibility

About

The German Inclisiran Network is a registry of patients with hypercholesterinemia on treatment with the siRNA inclisiran in Germany

Full description

The aim of this retrospective, multi-center analysis is to use individual patient data to determine the extent of the variability in LDL-C reduction in response to inclisiran administration in a real-world setting.

Enrollment

500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with elevated LDL-C levels (hypercholesterolemia) on stable lipid-lowering drugs for at least one month prior to the application of the siRNA Inclisiran
  • patients 18 years and older

Exclusion criteria

- patients who do not qualify for treatment with the siRNA inclisiran according to the G-BA (Gemeinsamer Bundesausschuß) in Germany.

Trial design

500 participants in 1 patient group

Patients with elevated LDL-cholesterol (hypercholesterolemia)
Description:
Application of si RNA Inclisiran to reduce serum LDL-cholesterol levels.

Trial contacts and locations

1

Loading...

Central trial contact

Martin Foerster, PhD; Oliver Weingaertner, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems